EUVIMEDEUVIMED entdecken
Übersichtsarbeit

RIFM Natural Complex Substance (NCS) fragrance ingredient safety assessment, benzoin infusion, Sumatra, CAS Registry Number 9000-05-9, RIFM ID 104-K2.31

A M Api, A Bartlett, D Belsito, D Botelho, M Bruze, A Bryant-Friedrich, G A Burton, M A Cancellieri, H Chon, M Cronin, S Crotty, M L Dagli und 22 weitere

Food and Chemical Toxicology · 2025

DOI: 10.1016/j.fct.2025.115774 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Food and Chemical Toxicology, 2025. Verfasst von A M Api und 33 weiteren Autor:innen. Beteiligte Einrichtung: Research Institute for Fragrance Materials, Inc., 1200 MacArthur Boulevard, Suite 306, Mahwah, NJ, 07430, USA. Hauptthemen laut MEDLINE: Perfume. Die Arbeit nennt 41 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Benzoin infusion, Sumatra was evaluated for genotoxicity, repeated dose toxicity, reproductive toxicity, local respiratory toxicity, photoirritation/photoallergenicity, skin sensitization, and environmental safety. Data for the components of the NCS do not show a concern for genotoxicity. Benzoin infusion, Sumatra was evaluated for the repeated dose and reproductive toxicity endpoints on the basis of component analysis using a combination of target data, read-across data, and the threshold of toxicological concern (TTC); benzoin infusion, Sumatra is safe for use under the conditions described in this safety assessment for the repeated dose and reproductive toxicity endpoints. Data for the components of the NCS do not show a concern for skin sensitization under the current, declared levels of use. The photoirritation endpoint was evaluated based on data and ultraviolet/visible (UV/Vis) absorption spectra for the components of the NCS; benzoin infusion, Sumatra is not expected to be photoirritating. Benzoin infusion, Sumatra has not been fully evaluated for photoallergenicity due to a lack of suitable data and validated in vitro tests. To address this data gap, RIFM is sponsoring an in vitro photoallergy research program to evaluate the photoallergy potential of benzoin infusion, Sumatra. The local respiratory toxicity endpoint for this NCS was evaluated using the inhalation TTC for a Cramer Class III material, and the inhalation exposure to benzoin infusion, Sumatra is below the TTC (0.47 mg/day). Based on the component assessment, benzoin infusion, Sumatra does not contain Persistent, Bioaccumulative, and Toxic (PBT) or very Persistent, very Bioaccumulative (vPvB) components as per the IFRA Environmental Standards. In addition, following the RIFM Environmental Framework and based on individual component assessment, benzoin infusion, Sumatra does not present a risk to the aquatic environment (i.e., its screening-level PEC/PNEC

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PerfumeHumansAnimalsRisk AssessmentToxicity TestsOdorantsMutagenicity Tests

Substanzen

Perfume

Autor:innen und Institutionen

  • Research Institute for Fragrance Materials, Inc., 1200 MacArthur Boulevard, Suite 306, Mahwah, NJ, 07430, USA.
  • Member Expert Panel for Fragrance Safety, Columbia University Medical Center, Department of Dermatology, 161 Fort Washington Ave., New York, NY, 10032, USA.
  • Member Expert Panel for Fragrance Safety, Malmo University Hospital, Department of Occupational & Environmental Dermatology, Sodra Forstadsgatan 101, Entrance 47, Malmo, SE-20502, Sweden.
  • Member Expert Panel for Fragrance Safety, Pharmaceutical Sciences, Wayne State University, 42 W. Warren Ave., Detroit, MI, 48202, USA.
  • Member Expert Panel for Fragrance Safety, School of Natural Resources & Environment, University of Michigan, Dana Building G110, 440 Church St., Ann Arbor, MI, 58109, USA.
  • Member Expert Panel for Fragrance Safety, Liverpool John Moores University, School of Pharmacy and Biomolecular Sciences, Liverpool, United Kingdom.

Zitieren

APA

Api, A. M., Bartlett, A., Belsito, D., Botelho, D., Bruze, M., Bryant-Friedrich, A., Burton, G. A., Cancellieri, M. A., Chon, H., Cronin, M., Crotty, S., Dagli, M. L., Dekant, W., Deodhar, C., Farrell, K., Fryer, A. D., Jones, L., Joshi, K., Lapczynski, A., …, & Thakkar, Y. (2025). RIFM Natural Complex Substance (NCS) fragrance ingredient safety assessment, benzoin infusion, Sumatra, CAS Registry Number 9000-05-9, RIFM ID 104-K2.31. Food and Chemical Toxicology. https://doi.org/10.1016/j.fct.2025.115774

Vancouver

Api AM, Bartlett A, Belsito D, Botelho D, Bruze M, Bryant-Friedrich A, et al. RIFM Natural Complex Substance (NCS) fragrance ingredient safety assessment, benzoin infusion, Sumatra, CAS Registry Number 9000-05-9, RIFM ID 104-K2.31. Food and Chemical Toxicology. 2025. doi:10.1016/j.fct.2025.115774

BibTeX
@article{Api2025,
  author = {Api, A M and Bartlett, A and Belsito, D and Botelho, D and Bruze, M and Bryant-Friedrich, A and Burton, G A and Cancellieri, M A and Chon, H and Cronin, M and Crotty, S and Dagli, M L and Dekant, W and Deodhar, C and Farrell, K and Fryer, A D and Jones, L and Joshi, K and Lapczynski, A and Laskin, D L and Lavelle, M and Lee, I and Moustakas, H and Muldoon, J and Penning, T M and Piersma, A H and Ritacco, G and Sadekar, N and Schember, I and Schultz, T W and Siddiqi, F and Sipes, I G and Sullivan, G and Thakkar, Y},
  title = {RIFM Natural Complex Substance (NCS) fragrance ingredient safety assessment, benzoin infusion, Sumatra, CAS Registry Number 9000-05-9, RIFM ID 104-K2.31},
  journal = {Food and Chemical Toxicology},
  year = {2025},
  doi = {10.1016/j.fct.2025.115774}
}
Kostenlos starten →